医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

EO and UVDI Lead Trans-Pacific Fight to Flatten the COVID-19 Curve

2020年06月25日 PM07:00
このエントリーをはてなブックマークに追加


 

VALENCIA, Calif.

EO Medical Pte. Ltd., announced in partnership with UltraViolet Devices, Inc. (UVDI), the global leader in UV-C disinfecting robots, that six additional UVDI-360 robots have been deployed in Singapore to curb the spread of coronavirus. UVDI-360 UV-C robots, manufactured in the greater Los Angeles area, are the most widely used disinfecting robot in Singapore’s top hospitals.

“Protecting the health of patients and healthcare personnel in Singapore demands scientifically proven solutions,” stated Loke Sai Yin, Managing Director, EO Medical. “The UVDI-360 robot is proven to reduce coronavirus by 99.99% in 5 minutes in independent testing and validated for use to eliminate coronavirus on 3M’s N95 respirators. These exciting results build on UVDI-360’s deep foundation of peer-reviewed, published clinical results reducing both Healthcare-Associated Infections and the highest-risk pathogens.”

“Singapore has demonstrated strong leadership in the fight against COVID-19,” added Richard Hayes, President, UVDI, Inc., “particularly via important social distancing measures. We are proud to build on these efforts in partnership with EO Medical to supply our advanced UV-C disinfecting robots to Singapore’s leading hospitals. Our manufacturing team is working around the clock to do so and will not stop until we defeat this pandemic, together.”

About EO Medical Pte. Ltd.

  • EO Medical believes in providing solutions through innovation, technology, and process improvement strategies. Delivering innovative hospital hygiene products and medical devices to Singapore’s healthcare systems since 2002.

About UltraViolet Devices, Inc. (UVDI)

  • UVDI’s Mission is to make a cleaner, safer, and healthier world through advanced UV-C solutions that disinfect the air we breathe and the environments we live, work and play in. Founded in 1949 by Louis Veloz, UVDI designs and makes next-generation germicidal Ultraviolet light solutions in California applying over 70 years and three generations of family craftsmanship and care. The state-of-the-art UVDI-360 Room Sanitizer is now used globally in over 25 countries in the world’s leading hospitals, where it has been proven in peer-reviewed, published studies to reduce Healthcare-Associated Infections and inactivate pathogens.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200625005070/en/

CONTACT

Press Contact | UVDI, Inc.

Will Gerard

661.689.2741

will.gerard@uvdi.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
  • Taiwan Innotech Expo (TIE) Showcases Strong Ecosystems in the Post-Pandemic World
  • Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market
  • GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
  • 随着越来越多的客户和合作伙伴使用Denodo冠状病毒数据门户计划来对抗和最小化COVID-19的影响,其采纳率在不断提高